February 8, 2005 — The investigational agent, azimilide dihydrochloride, a class III antiarrhythmic drug with potassium channel-blocking properties, significantly reduces the need for shocks or ...
December 3, 2004 — Programming implantable cardioverter defibrillators (ICDs) to use antitachycardia pacing (ATP) as a first therapy for fast ventricular tachycardia (FVT) reduces the need for shocks ...
BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...